Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(847)
Wynne Aherne
34
Florence I. Raynaud
32
Paul A. Clarke
32
Suzanne A. Eccles
27
Ian R. Judson
21
Journals
(78)
EJC SUPPL
23
BRIT J CANCER
15
CANCER CHEMOTHER PHARMACOL
12
CANCER RES
10
MOL CANCER THER
10
Keywords
(363)
Embed
Subscribe
Academic
Authors
Paul Workman
Paul Workman,Institute of Cancer Research,Oncology,Pharmacology,Medicinal Chemistry
Edit
Paul Workman
Institute of Cancer Research
Publications:
244
|
Citations:
3962
Fields:
Oncology
,
Pharmacology
,
Medicinal Chemistry
View FAQ about top research areas and Fields of study
Collaborated with
847 co-authors
from 1992 to 2012
|
Cited by
10360 authors
Cumulative
Annual
Sort by:
Publications
(244)
BibTeX
|
RIS
|
RefWorks
Download
Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling
Simon R. Stockwell
,
Georgina Platt
,
S. Elaine Barrie
,
Georgia Zoumpoulidou
,
Robert H. te Poele
,
G. Wynne Aherne
,
Stuart C. Wilson
,
Peter Sheldrake
,
Edward McDonald
,
Mathilde Venet
,
Christelle Soudy
,
Frédéric Elustondo
Paul Workman
http://academic.research.microsoft.com/io.ashx?type=5&id=57401697&selfId1=19785435&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 1, 2012
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
Stuart C. Wilson
,
Butrus Atrash
,
Clare Barlow
,
Susan Eccles
,
Peter M. Fischer
,
Angela Hayes
,
Lloyd Kelland
,
Wayne Jackson
,
Michael Jarman
,
Amin Mirza
,
Javier Moreno
,
Bernard P. Nutley
Paul Workman
http://academic.research.microsoft.com/io.ashx?type=5&id=49486787&selfId1=19785435&selfId2=0&maxNumber=12&query=
Journal:
Bioorganic & Medicinal Chemistry - BIOORGAN MED CHEM
, vol. 19, no. 22, pp. 6949-6965, 2011
Chemical biology: Many faces of a cancer-supporting protein
(
Citations: 1
)
John F. Darby
,
Paul Workman
Journal:
Nature
, vol. 478, no. 7369, pp. 334-335, 2011
Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacements
Jonathan M. Large
,
Jane E. Torr
,
Florence I. Raynaud
,
Paul A. Clarke
,
Angela Hayes
,
Francesca di Stefano
,
Frederique Urban
,
Stephen J. Shuttleworth
,
Nahid Saghir
,
Peter Sheldrake
,
Paul Workman
,
Edward McDonald
Journal:
Bioorganic & Medicinal Chemistry - BIOORGAN MED CHEM
, vol. 19, no. 2, pp. 836-851, 2011
Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
(
Citations: 1
)
Paul Workman
Journal:
Cancer Cell
, vol. 19, no. 4, pp. 437-440, 2011
Sort by:
Citations
(3962 times by 2504 publications)
The Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF Kinase
(
Citations: 3
)
Peng Xie
,
Craig Streu
,
Jie Qin
,
Howard Bregman
,
Nicholas Pagano
,
Eric Meggers
,
Ronen Marmorstein
Journal:
Biochemistry - BIOCHEMISTRY-USA
, vol. 48, no. (23), pp. 5187-5198, 2012
Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling
Simon R. Stockwell
,
Georgina Platt
,
S. Elaine Barrie
,
Georgia Zoumpoulidou
,
Robert H. te Poele
,
G. Wynne Aherne
,
Stuart C. Wilson
,
Peter Sheldrake
,
Edward McDonald
,
Mathilde Venet
,
Christelle Soudy
,
Frédéric Elustondo
Paul Workman
http://academic.research.microsoft.com/io.ashx?type=5&id=57401697&selfId1=19785435&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 1, 2012
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1
H Gaude
,
N Aznar
,
A Delay
,
A Bres
,
K Buchet-Poyau
,
C Caillat
,
A Vigouroux
,
C Rogon
,
A Woods
,
J-M Vanacker
,
J Höhfeld
,
C Perret
http://academic.research.microsoft.com/io.ashx?type=5&id=56651385&selfId1=19785435&selfId2=0&maxNumber=12&query=
Journal:
Oncogene
, vol. 31, no. 12, pp. 1582-1591, 2012
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes
Jeffrey J. Wallin
,
Jane Guan
,
Kyle A. Edgar
,
Wei Zhou
,
Ross Francis
,
Anthony C. Torres
,
Peter M. Haverty
,
Jeffrey Eastham-Anderson
,
Sabrina Arena
,
Alberto Bardelli
,
Sue Griffin
,
John E. Goodall
http://academic.research.microsoft.com/io.ashx?type=5&id=57404312&selfId1=19785435&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 5, 2012
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
T Smirnova
,
Z N Zhou
,
R J Flinn
,
J Wyckoff
,
P J Boimel
,
M Pozzuto
,
S J Coniglio
,
J M Backer
,
A R Bresnick
,
J S Condeelis
,
N E Hynes
,
J E Segall
Journal:
Oncogene
, vol. 31, no. 6, pp. 706-715, 2012
Comments